Victory Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.1M Buy
415,733
+405,303
+3,886% +$14.7M 0.01% 974
2025
Q1
$378K Buy
10,430
+124
+1% +$4.49K ﹤0.01% 2085
2024
Q4
$434K Sell
10,306
-642
-6% -$27K ﹤0.01% 2062
2024
Q3
$608K Buy
10,948
+884
+9% +$49.1K ﹤0.01% 1958
2024
Q2
$414K Sell
10,064
-95
-0.9% -$3.9K ﹤0.01% 2026
2024
Q1
$474K Sell
10,159
-406
-4% -$19K ﹤0.01% 1996
2023
Q4
$505K Buy
10,565
+3,259
+45% +$156K ﹤0.01% 1993
2023
Q3
$260K Buy
7,306
+156
+2% +$5.56K ﹤0.01% 2155
2023
Q2
$330K Sell
7,150
-167
-2% -$7.7K ﹤0.01% 2095
2023
Q1
$293K Sell
7,317
-75
-1% -$3.01K ﹤0.01% 2150
2022
Q4
$342K Sell
7,392
-3
-0% -$139 ﹤0.01% 2140
2022
Q3
$306K Sell
7,395
-73
-1% -$3.02K ﹤0.01% 2240
2022
Q2
$446K Buy
7,468
+9
+0.1% +$537 ﹤0.01% 2105
2022
Q1
$527K Buy
7,459
+21
+0.3% +$1.48K ﹤0.01% 2110
2021
Q4
$625K Buy
7,438
+823
+12% +$69.2K ﹤0.01% 2042
2021
Q3
$597K Buy
6,615
+448
+7% +$40.4K ﹤0.01% 2080
2021
Q2
$588K Sell
6,167
-250
-4% -$23.8K ﹤0.01% 2112
2021
Q1
$731K Sell
6,417
-343
-5% -$39.1K ﹤0.01% 2041
2020
Q4
$936K Buy
6,760
+2,040
+43% +$282K ﹤0.01% 1817
2020
Q3
$388K Sell
4,720
-304
-6% -$25K ﹤0.01% 2054
2020
Q2
$393K Sell
5,024
-5,606
-53% -$439K ﹤0.01% 2068
2020
Q1
$472K Buy
10,630
+3,230
+44% +$143K ﹤0.01% 2112
2019
Q4
$316K Buy
7,400
+1,087
+17% +$46.4K ﹤0.01% 2188
2019
Q3
$270K Buy
+6,313
New +$270K ﹤0.01% 2111
2018
Q4
Sell
-510
Closed -$39K 1809
2018
Q3
$39K Buy
510
+67
+15% +$5.12K ﹤0.01% 1736
2018
Q2
$34K Hold
443
﹤0.01% 1777
2018
Q1
$23K Hold
443
﹤0.01% 1786
2017
Q4
$21K Hold
443
﹤0.01% 1784
2017
Q3
$24K Hold
443
﹤0.01% 1770
2017
Q2
$28K Buy
443
+43
+11% +$2.72K ﹤0.01% 1761
2017
Q1
$27K Buy
400
+78
+24% +$5.27K ﹤0.01% 1751
2016
Q4
$23K Buy
322
+28
+10% +$2K ﹤0.01% 1749
2016
Q3
$21K Buy
+294
New +$21K ﹤0.01% 1749